SeqLL Inc. (SQL)

$1

-0.02 (-1.96%)
Rating:
Recommendation:
-
Symbol SQL
Price $1
Beta 0.000
Volume Avg. 0.05M
Market Cap 11.886M
Shares () -
52 Week Range 0.61-5.8
1y Target Est -
DCF Unlevered SQL DCF ->
DCF Levered SQL LDCF ->
ROE -69.57% Strong Sell
ROA -53.96% Strong Sell
Operating Margin -
Debt / Equity 58.42% Buy
P/E -
P/B 1.87 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Diagnostics & Research
NASDAQ Capital Market

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.